Navigation Links
Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
Date:11/14/2012

h plasma therapy and collagen sheet products.  These case studies and physician feedback provide additional information regarding the potential uses of Excellagen and support its medical utility as an important new tool to help promote the wound healing process.Since receiving FDA clearance for Excellagen, Cardium has established cGMP out-sourced manufacturing and supply with UK-based Angel Biotechnology, developed cold chain logistics and distribution with Smith Medial Partners, initiated a pathway toward securing private payer and government product reimbursement, including Centers for Medicare & Medicaid Services (CMS), and assembled an internal strategic and tactical sales and marketing team.  Already-established standard CPT® procedure reimbursement codes may apply when Excellagen is used is administered with surgical debridement procedures.  The Company is currently engaged in physician relationship building with key opinion leaders, product sampling, practice integration, and building a portfolio of physician case studies.  Excellagen is a key asset in Cardium's medical opportunities portfolio and represents the first product from the Company's regenerative medicine platform.  Excellagen has been engineered to serve as a delivery platform enabling multiple device and therapeutic product extensions (via 510(k) and IDE pathways) to include Excellagen-based antimicrobials, small molecule drugs, peptides, conditioned cell media, stem cells and DNA-based biologic products.  A detailed presentation on Excellagen's commercialization status can be viewed at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.Consistent with its long-term business strategy, and similar to the business strategy for the Company's InnerCool operating unit, which was successfully developed and sold to Philips Electronics, Cardium
'/>"/>
SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
2. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
3. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
4. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
5. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
6. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
7. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
8. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
9. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
10. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
11. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... N.J. , March 5, 2015 Soligenix, ... stage biopharmaceutical company committed to developing products that address ... and biodefense, announced today that its President and Chief ... give a corporate presentation at the 27 th ... , on Tuesday, March 10, 2015 at 1:00 ...
(Date:3/5/2015)...  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... to be held March 8-11, 2015, in ... Sapirstein , Chief Executive Officer, will provide an overview ... will be available to participate in one-on-one meetings with ...
(Date:3/5/2015)... , March 5, 2015 ... the new generation of OASIS *    at ... enhanced processing power will set a benchmark for patient-centric ... obstacles and prevent delays whilst optimizing workflow management and ... patient comfort and safety for imaging in Neurology, Orthopaedics, ...
Breaking Medicine Technology:Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3ContraVir to Present at 27th Annual ROTH Conference 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3
... ACEL ) today announced that 311 evaluable events (patient ... its lead compound,ONCONASE, for the treatment of patients with ... trial was,closed on Sept. 30, 2007. A total of ... with the statistical plan for the study, the company ...
... Inverseon, Inc.,( http://www.inverseon.com ) announces the publication of ... In the article by Hanania et al., in ... entitled, "The safety and,effects of the beta-blocker, nadolol, ... were treated for 9 weeks. All subjects tolerated,the ...
Cached Medicine Technology:Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2Inverseon Announces Positive Phase IIa Asthma Study 2
(Date:3/5/2015)... 2015 As a result of ... of Clearstream, LLC ’s products, services and ... line of products—led by their mPulse Hand Sanitizer—fits ... Program. , The AAPA—which represents a profession comprising ... and surgical specialties in the U.S.—advocates and educates ...
(Date:3/5/2015)... Menlo Park, California (PRWEB) March 05, 2015 ... Psychopharmacology (JCAP) last week released a special ... experts in the field of PANDAS (Pediatric Autoimmune ... Acute-onset Neuropsychiatric Syndromes), an autoimmune reaction triggered by ... and lyme, which result in inflammation of the ...
(Date:3/5/2015)... March 05, 2015 Wimbledon Health ... provides vascular, echocardiogram and NCV testing, announced ... the Chief Medical Officer. Dr. Artel will be responsible ... of the WimbledonMED program and the continued growth and ... about working with Wimbledon Health Partners as a consulting ...
(Date:3/5/2015)... March 5, 2015 – As National Patient Safety ... 2015), children’s hospitals around the country are affirming the ... as safe as possible for their children. , A ... Patient Safety (SPS) and the Children’s Hospital Association—are collaborating ... visiting the hospital with their child. , “SPS ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course has been ... variety of dental disciplines, to offer implant placement treatment ... onset we wanted this course to be a truly ... excellence of the lecturers and the sheer energy and ... satisfied our aims." , Unlike large-scale training operations, ...
Breaking Medicine News(10 mins):Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 2Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 4Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2
... Germany have used a magnetic resonance imaging (MRI) technique ... blood flow patterns in schizophrenic patients quickly and without ... the online edition and July printed issue of the ... a powerful technique that can help reduce the cost ...
... The National Institute of Diabetes and Digestive and ... (NIH) has awarded Albert Einstein College of Medicine of ... continuation of its Diabetes Research and Training Center (DRTC). ... for equipment and additional pilot and feasibility studies through ...
... new treatment known as a visually-guided laser-balloon catheter ... pigs with intermittent, irregular heartbeats, in a study ... a journal of the American Heart Association. , ... procedure called ablation, which destroys a group of ...
... ... , ... 2010 -- Blue Cross Blue Shield of Massachusetts, Inc. (BCBSMA) and Northeast Health ... Quality Contract (AQC). The agreement marks the first North Shore physician group to adopt ...
... Medical School report in the journal Nature Medicine on ... glioma, a pathway essential to the cancer,s ability to ... would stop the cancer,s ability to thrive. ... interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in ...
... is the prevalence of hypertension in U.S. not decreasing , ... of Americans with high blood pressure has not declined in ... more people with the condition have it under control. , ... risk factor for heart attack, stroke and other cardiovascular problems; ...
Cached Medicine News:Health News:Blood flows differently through the brains of schizophrenic patients 2Health News:NIH awards $10M to Einstein for diabetes research 2Health News:NIH awards $10M to Einstein for diabetes research 3Health News:Visually guided laser may be viable treatment for abnormal heartbeat 2Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 2Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 3Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 4Health News:Novel RNA interference screening technique identifies possible path for malignant glioma treatment 2Health News:Report Finds Control of High Blood Pressure Improving 2Health News:Report Finds Control of High Blood Pressure Improving 3
Multiwindow transcranial and peripheral Doppler system....
... Multi frequency and ... emboli detection and fitted ... and tests for hemodynamic ... suitable as well for ...
One channel transcranial Doppler...
... an advanced Doppler system that allows non-invasive ... body. This method of measurement is particularly ... blood to the brain. , ,TCD is ... problems such as vasospasm and intracranial stenosis. ...
Medicine Products: